| Literature DB >> 33973667 |
Nicola Chirico1, Alessandro Sangion1,2, Paola Gramatica1, Linda Bertato1, Ilaria Casartelli1, Ester Papa1.
Abstract
The new software QSARINS-Chem standalone version is a multiplatform tool, freely downloadable, for the in silico profiling of multiple properties and activities of organic chemicals. This software, which is based on the concept of the QSARINS-chem module embedded in the QSARINS software, has been fully redesigned and redeveloped in the Java™ language. In addition to a selection of models included in the old module, the new software predicts biotransformation rates and aquatic toxicities of pharmaceuticals and personal care products in multiple organisms, and offers a suite of tools for the analysis of predictions. Furthermore, a comprehensive and transparent database of molecular structures is provided. The new QSARINS-Chem standalone version is an informative and solid tool, which is useful to support the assessment of the potential hazard and risks related to organic chemicals and is dedicated to users which are interested in the application of QSARs to generate reliable predictions.Entities:
Keywords: QSAR; QSARINS; alternatives to animal testing; in silico predictions; virtual screening
Mesh:
Substances:
Year: 2021 PMID: 33973667 PMCID: PMC8251994 DOI: 10.1002/jcc.26551
Source DB: PubMed Journal: J Comput Chem ISSN: 0192-8651 Impact factor: 3.376
List of the datasets , , , , , , , , , , , , , , , , , , , , , , , , , , , , , included in the structural database of QSARINS‐Chem standalone version
| Class | Endpoint‐type | Dataset name |
|---|---|---|
| 1. General | 1. Physico‐Chemical properties | 1. Soil organic carbon‐water partition coefficient (KOC) |
| 2. Environmental Persistence | 1. Sediment half‐lives | |
| 2. Soil half‐lives | ||
| 3. Water half‐lives | ||
| 4. Air half‐lives | ||
| 5. NO3 reactivity | ||
| 6. O3 reactivity | ||
| 7. OH reactivity | ||
| 8. Global half‐life index (GHLI) | ||
| 3. Bioconcentration Factor (BCF) | 1. BCF‐Fernandez | |
| 2. BCF‐Lu | ||
| 4. Metabolic Transformation | 1. Fish biotransformation | |
| 2. Human biotransformation Model 1 | ||
| 3. Human biotransformation Model 2 | ||
| 4. Human biotransformation Model 3 | ||
| 5. Human biotransformation Model 4 | ||
| 6. Human total elimination | ||
| 5. Aquatic Toxicity | 1. Fish acute toxicity ( | |
| 6. Endocrine Disruption | 1. Estrogen receptor binding | |
| 2. Aromatic Amines | 1. Mutagenicity | 1. Aromatic Amines mutagenicity TA98 |
| 2. Aromatic amines mutagenicity TA100 | ||
| 3. (Benzo)Triazoles | 1. Physico‐Chemical properties | 1. (B)TAZ Kow |
| 2. (B)TAZ solubility in water | ||
| 3. (B)TAZ vapor pressure | ||
| 4. (B)TAZ melting point | ||
| 2. Aquatic Toxicity | 1. (B)TAZ Algae acute toxicity ( | |
| 2. (B)TAZ | ||
| 3. (B)TAZ fish acute toxicity ( | ||
| 4. Brominated flame retardants (BFR) | 1. Physico‐Chemical properties | 1. BFR Kow |
| 2. BFR Koa | ||
| 3. BFR vapor pressure | ||
| 4. BFR solubility in water | ||
| 5. BFR Henry law constant | ||
| 6. BFR melting point | ||
| 2. Endocrine Disruption | 1. BFR‐DR‐Ag | |
| 2. BFR‐ER‐Ag | ||
| 3. BFR‐ERODind | ||
| 4. BFR‐PR‐ant | ||
| 5. BFR‐SULT‐REP | ||
| 6. BFR‐T4‐REP | ||
| 7. BFR receptor binding affiniy | ||
| 5. Dioxin analogues | 1. Biochemical Activity | 1. Dioxin analogues pAH |
| 2. Dioxin analogues pRB | ||
| 6. Esters | 1. Physico‐Chemical properties | 1. Esters flash point |
| 2. Aquatic Toxicity | 1. Esters Algae acute toxicity | |
| 2. Esters | ||
| 3. Esters fish acute toxicity ( | ||
| 4. Esters aquatic toxicity index (EATIN) | ||
| 7. Fragrances | 1. Terrestrial Toxicity | 1. Fragrances oral toxicity (Rat) |
| 2. Biochemical Activity | 1. Fragrances inhibition NADHox | |
| 2. Fragrances Mitochondrial memb pot | ||
| 8. Nitrated polycyclic aromatic hydrocarbons (PAH) | 1. Mutagenicity | 1. NitroPAH mutagenicity TA100 |
| 9. Perfluorinated compounds | 1. Physico‐Chemical properties | 1. PFC critical Micelle concentration |
| 2. PFC solubility in water | ||
| 3. PFC vapor pressure | ||
| 2. Terrestrial Toxicity | 1. PFC oral toxicity (Rat) | |
| 2. PFC oral toxicity (Mouse) | ||
| 3. PFC inhalation toxicity (Rat) | ||
| 4. PFC inhalation toxicity (Mouse) | ||
| 10. Personal care products | 1. Aquatic Toxicity | 1. PCP Algae acute toxicity ( |
| 2. PCP | ||
| 3. PCP fish acute toxicity ( | ||
| 11. Pharmaceuticals | 1. Aquatic Toxicity | 1. Pharm. Algae acute toxicity ( |
| 2. Pharm. | ||
| 3. Pharm. fish acute toxicity ( | ||
| 4. Pharm. fish acute toxicity ( |
Class 1 includes heterogeneous structures; Class 2–11 refer to specific chemical classes or classes of use.
FIGURE 2Vertical blue bars indicate the number of records included in each class of chemicals commented in the text (11 classes listed in Table 1)
List of the QSAR models included in QSARINS‐Chem standalone version
| Category | Model |
|
|---|---|---|
| Physico‐chemical properties | 1. Soil organic carbon‐water partition coefficient (KOC) | 643 |
| Global indexes | 1. Global half‐life index (GHLI) | 250 |
| 2. Insubria PBT index | 180 | |
| Aquatic toxicity | 1. Fish acute toxicity ( | 449 |
| Aquatic toxicity of personal care products (PCPs) | 1. PCP freshwater Algae growth inhibition | 20 |
| 2. PCP | 72 | |
| 3. PCP fish acute toxicity Model 1 (logP based) | 67 | |
| 4. PCP fish acute toxicity Model 2 | 67 | |
| 5. PCP aquatic toxicity index (ATI) | 484 | |
| Aquatic toxicity of pharmaceuticals | 1. Pharmaceutical freshwater Algae growth inhibition | 45 |
| 2. Pharmaceutical | 125 | |
| 3. Pharmaceutical fish acute toxicity ( | 55 | |
| 4. Pharmaceutical fish acute toxicity ( | 62 | |
| 5. Pharmaceutical aquatic toxicity index (ATI) | 706 | |
| Metabolic transformation in fish | 1. Fish biotransformation Model 1 | 632 |
| 2. Fish biotransformation Model 2 | 632 | |
| 3. Fish biotransformation Model 3 | 632 | |
| Metabolic transformation in human | 1. Human biotransformation Model 1 | 1011 |
| 2. Human biotransformation Model 2 | 1015 | |
| 3. Human biotransformation Model 3 | 935 | |
| 4. Human biotransformation Model 4 | 940 | |
| 5. Human total elimination | 1105 |
FIGURE 3QSARINS‐Chem diagnostic plots. Upper left: Plot of diagonal values from the HAT matrix versus estimated values of the endpoint (“Insubria graph”); upper right: Plot of experimental versus estimated values of the endpoint; lower left: Plot of estimated values of the endpointversus residuals; lower right: Plot of diagonal values from the HAT matrix versus standardized residuals (“Williams plot”). Colors: Red dots = training set; dark blue dots = user set, when the experimental value of the endpoint is provided by the user; light blue dots = user set, when the experimental value of the endpoint is not provided by the user